Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.38 0.00 (-0.36%)
As of: Oct 1, 2026 · 10:06 AM EDT

Alx Oncology Holdings (ALXO) Receivables - Accured (2022 - 2023)

Updated

Alx Oncology Holdings (ALXO) posted Receivables - Accured of $182,000 for Q1 2023, up 133.3% from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Receivables - Accured (2022 - 2023) Analysis & Trends

At the end of FY2022, Alx Oncology Holdings' Receivables - Accured came in at $78,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables - Accured (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Alx Oncology Holdings 192.12 Mn 192.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 182,000.00
Dec 31, 2022 78,000.00
Sep 30, 2022 48,000.00
API Access

Alx Oncology Holdings Receivables - Accured API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-accured&ticker=ALXO&period=max&api_key=YOUR_API_KEY